SPRY
SPRY
NASDAQ · Biotechnology

Ars Pharmaceuticals Inc

Small-Cap Stocks Stocks Under $10 Biotech Stocks Healthcare Stocks
$8.56
+0.30 (+3.63%)
As of May 9, 1:38 AM ET ·
Analyst Consensus
Strong Buy
13
Analysts
Moderate
Coverage
Buy 12 92%
Hold 1 8%
Sell 0 0%
Price Target
Analyst Price Target +670.0% upside
Low Target $44.11
Average Target $65.91
High Target $67.85
Current Price $8.56
Current
$8.56
Target
$65.91
$44.11 $65.91 avg $67.85
Scenario Analysis
Bear Case
$44.11
415.3%
Low target
Base Case
$65.91
+670.0%
Avg target
Bull Case
$67.85
+692.6%
High target
Risk/Reward
1.7x
Balanced
Price in Context
52-Week High
$18.90
-54.7% from high
52-Week Low
$6.66
+28.5% from low
Target vs 52W High
$65.91
+248.7% vs high
Next Earnings Report
May 15, 2026 · After Market Close
4d
until earnings
EPS Est: $-0.51
Earnings in 4 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 75% $257.58 +27.8%
AMGN
Amgen Inc
 Hold 44 48% $190.87 -42.5%
GILD
Gilead Sciences Inc
 Strong Buy 39 79% $362.68 +176.2%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 +2.0%
REGN
Regeneron Pharmaceuticals
 Strong Buy 38 79% $76.80 -89.3%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 75% $102.31 -65.3%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -19.5%
INSM
Insmed Inc
 Strong Buy 28 96% $143.40 +41.5%